Finzati - Logo
HUM logo

Humana Inc.

HUMMedical - Healthcare Plans
$401.54
-4.98 (-1.23%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$48.54B
Growth
9.3%
Cash Flow
5/5
Trend
Stable
Evidence
Positive revenue growth · 13.4%Positive free cash flow · 3.11Consistent free cash flow · 5/5Manageable debt level · 0.73Weak liquidity · 0.72
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$401.54
Change-1.23%
Shares Out120.89M
Market Cap$48.54B
Enterprise Value$38.92B
52W Range163.11 - 428.88
Beta0.72
P/E37.98
P/S0.33
P/B2.53
P/FCF-109.58
EV/Sales0.27

Investment DNA

How strong this company looks for long-term investors

53
out of 100
Business Quality
Margins, moat, returns
27/100
Financial Strength
Debt, cash, stability
39/100
Growth Potential
Revenue and expansion
58/100
Price Attractiveness
Cheap or expensive today
64/100
Why this score
Positive revenue growth · 13.4%Positive free cash flow · 3.11Consistent free cash flow · 5/5Manageable debt level · 0.73Weak liquidity · 0.72Weak profitability

Analyst view

Analyst sentiment and price target

HUM
Analyst sentiment
Based on 44 analyst votes · 2026-09-05
67/100
Neutral
Bullish
16
Hold
27
Bearish
1
Price Target
2026-07-31
Low
$249.00
Mean
$410.06
Median
$412.50
High
$513.00

Company Overview

IPO: 12/31/1981
Industry: Medical - Healthcare Plans
P/B i: 2.53
Debt / Equity i: 0.73
Operating Margin: 1.12%
Net Margin: 0.92%
ROE i: -
ROIC: -

Financial Health

Score8 / 20
Debt / Equity: 0.73
Current Ratio: 0.72
Quick Ratio: 0.72
Status: Moderate

Warnings

  • Weak Liquidity
  • Weak quick ratio

Insider Transactions

Recent executive and insider activity

Smith Paul John
Transaction: 07/28/2026
OTHER
Change
0
Price
Not reported
Filing
07/29/2026
Type
OTHER
Crawford Frederick John
Transaction: 07/28/2026
OTHER
Change
0
Price
Not reported
Filing
07/29/2026
Type
OTHER
HILZINGER KURT J
Transaction: 06/30/2026
BUY
Change
+233
Price
Not reported
Filing
07/02/2026
Type
BUY